Anti-O2T35/ OR2T35 monoclonal antibody

Anti-O2T35/ OR2T35 antibody for FACS & in-vivo assay

Target products collectionGo to OR2T35/OR2T35 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1071-Ab-1/ GM-Tg-hg-MP1071-Ab-2Anti-Human OR2T35 monoclonal antibodyHuman
GM-Tg-rg-MP1071-Ab-1/ GM-Tg-rg-MP1071-Ab-2Anti-Rat OR2T35 monoclonal antibodyRat
GM-Tg-mg-MP1071-Ab-1/ GM-Tg-mg-MP1071-Ab-2Anti-Mouse OR2T35 monoclonal antibodyMouse
GM-Tg-cynog-MP1071-Ab-1/ GM-Tg-cynog-MP1071-Ab-2Anti-Cynomolgus/ Rhesus macaque OR2T35 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1071-Ab-1/ GM-Tg-felg-MP1071-Ab-2Anti-Feline OR2T35 monoclonal antibodyFeline
GM-Tg-cang-MP1071-Ab-1/ GM-Tg-cang-MP1071-Ab-2Anti-Canine OR2T35 monoclonal antibodyCanine
GM-Tg-bovg-MP1071-Ab-1/ GM-Tg-bovg-MP1071-Ab-2Anti-Bovine OR2T35 monoclonal antibodyBovine
GM-Tg-equg-MP1071-Ab-1/ GM-Tg-equg-MP1071-Ab-2Anti-Equine OR2T35 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1071-Ab-1/ GM-Tg-hg-MP1071-Ab-2; GM-Tg-rg-MP1071-Ab-1/ GM-Tg-rg-MP1071-Ab-2;
GM-Tg-mg-MP1071-Ab-1/ GM-Tg-mg-MP1071-Ab-2; GM-Tg-cynog-MP1071-Ab-1/ GM-Tg-cynog-MP1071-Ab-2;
GM-Tg-felg-MP1071-Ab-1/ GM-Tg-felg-MP1071-Ab-2; GM-Tg-cang-MP1071-Ab-1/ GM-Tg-cang-MP1071-Ab-2;
GM-Tg-bovg-MP1071-Ab-1/ GM-Tg-bovg-MP1071-Ab-2; GM-Tg-equg-MP1071-Ab-1/ GM-Tg-equg-MP1071-Ab-2
Products NameAnti-OR2T35 monoclonal antibody
Formatmab
Target NameOR2T35
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OR2T35 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species O2T35/ OR2T35 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1071
    Target NameOR2T35
    Gene ID403244
    Gene Symbol and SynonymsOR2T35
    Uniprot AccessionQ8NGX2
    Uniprot Entry NameO2T35_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000177151
    Target ClassificationN/A

    The target: OR2T35, gene name: OR2T35, also named as . 0.



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.